CARE™ Congress 2020: Update on Biosimilars & Access to Innovation
Join us for the 4th National CARE™ Congress: Access to Innovation! This meeting addresses questions and considerations regarding Biosimilars in Canada and how they build towards a larger discussion on access to innovative medicine.
This meeting will include discussion and will provide a platform for medical specialists and key stakeholders across multiple fields to meet, collaborate, and discuss concepts that have a practical impact on the Canadian healthcare landscape.
The CARE™ Congress aims to allow assembled CARE™ faculty and panelists to consider the use of biosimilars and align on the importance of access to innovation.
The CARE™ Faculty is pleased to welcome a robust speaker line-up, with representation from Canadian researchers, clinicians, government, public and private funding agencies, and hospital pharmacists.